In addition, there was facilitated or reduced ELAVL1 enrichment on CD44 pre-mRNA in gastric cancer cells with stable over-expression or knockdown of CMTR1, while silencing or ectopic expression of SNORA37 abolished these effects (Fig. 6f and Additional file 1: Fig. S7b, c). This evidence concerns the gene ELAVL1 and gastric cancer.